Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

978
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
978
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coping with primary brain tumors together: a scoping review of dyadic psychosocial interventions.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Distress and Emotional Support Needs of Patients With Stage IV Cancer and Their Partners: A Biopsychosocial Assessment.

Psycho-oncology·2025
Same author

Understanding the relationship between body image and emotional distress among men and women with cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial.

JMIR cancer·2024
Same author

Rapid and sensitive detection of genome contamination at scale with FCS-GX.

Genome biology·2024
Same author

Development of an ambulatory assessment unit - acute oncology service MDT to provide safe follow up of new oncology patients presenting to an SDEC unit.

Clinical medicine (London, England)·2024

Related Experiment Video

Updated: Apr 26, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

Update on latent tuberculosis infection.

Holly Hartman-Adams1, Karen Clark1, Gregory Juckett1

  • 1West Virginia University Robert C. Byrd Health Science Center School of Medicine, Morgantown, WV, USA.

American Family Physician
|August 1, 2014
PubMed
Summary
This summary is machine-generated.

Latent tuberculosis infection (LTBI) carries a lifetime risk of progressing to active disease. New treatments offer effective alternatives to standard therapy, improving outcomes for individuals with LTBI.

More Related Videos

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Related Experiment Videos

Last Updated: Apr 26, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

19.9K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Latent tuberculosis infection (LTBI) is asymptomatic but poses a 5-10% lifetime risk of progression to active tuberculosis (TB).
  • High-risk groups for LTBI include immigrants, healthcare workers, institutional residents, and homeless individuals.
  • Progression to active TB is influenced by immunodeficiency, recent exposure, and chronic kidney disease.

Purpose of the Study:

  • To review diagnostic methods for LTBI, including tuberculin skin testing (TST) and interferon-gamma release assays (IGRAs).
  • To discuss risk factors for LTBI progression and treatment options.
  • To compare the effectiveness of newer TB preventive therapies with standard regimens.

Main Methods:

  • Literature review of diagnostic tests for LTBI, focusing on TST and IGRA limitations and indications.
  • Analysis of risk factors associated with progression from latent to active TB.
  • Evaluation of current and novel treatment regimens for LTBI prevention.

Main Results:

  • TST has limitations including false positives from BCG vaccination or environmental mycobacteria exposure.
  • IGRAs offer an alternative to TST, particularly for BCG-vaccinated individuals or those unlikely to return for TST reading.
  • Newer regimens, such as 12 weekly doses of isoniazid and rifapentine or a four-month rifampin regimen, show comparable or superior effectiveness to standard nine-month isoniazid therapy.

Conclusions:

  • Accurate diagnosis of LTBI is crucial, with TST and IGRAs having distinct advantages and disadvantages.
  • Identifying and managing LTBI in high-risk populations is essential for TB control.
  • Novel, shorter LTBI treatment regimens provide effective alternatives to prolonged daily therapy, potentially improving patient adherence and outcomes.